Empirical Financial Services LLC d.b.a. Empirical Wealth Management Sells 211 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Empirical Financial Services LLC d.b.a. Empirical Wealth Management cut its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 14.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,249 shares of the biotechnology company’s stock after selling 211 shares during the quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Axon Enterprise were worth $742,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Insigneo Advisory Services LLC increased its holdings in Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after acquiring an additional 22 shares in the last quarter. Menard Financial Group LLC increased its holdings in Axon Enterprise by 0.8% in the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after acquiring an additional 24 shares in the last quarter. PFG Investments LLC increased its holdings in Axon Enterprise by 0.6% in the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after acquiring an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC increased its holdings in Axon Enterprise by 1.6% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after acquiring an additional 26 shares in the last quarter. Finally, Mather Group LLC. increased its holdings in Axon Enterprise by 3.7% in the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after acquiring an additional 27 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JMP Securities boosted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $524.85.

Insider Activity

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the sale, the insider now owns 154,394 shares in the company, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Trading Up 5.4 %

Shares of AXON stock opened at $637.53 on Wednesday. The company’s 50-day moving average price is $618.29 and its 200-day moving average price is $476.64. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $48.61 billion, a price-to-earnings ratio of 164.74, a PEG ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.